Literature DB >> 28345293

Detection of Zaire ebolavirus in swine: Assay development and optimization.

B S Pickering1, B Collignon1, G Smith1, P Marszal1, G Kobinger2, H M Weingartl1,3.   

Abstract

Ebolaviruses (family Filoviridae, order Mononegavirales) cause often fatal, haemorrhagic fever in primates including humans. Pigs have been identified as a species susceptible to Reston ebolavirus (RESTV) infection, with indicated transmission to humans in the Philippines; however, their role during Ebola outbreaks in Africa needs to be clarified. To perform surveillance studies, detection of ebolavirus requires a prerequisite validation of viral RNA and antibody detection methods in swine samples. These diagnostic tests also need to be suitable for deployment to low-level containment laboratories. In this study, we developed a set of tests for detection of antibodies against Zaire ebolavirus (EBOV) in swine. Recombinant EBOV nucleoprotein was produced using a baculovirus expression system for indirect ELISA development. Evaluation of this assay was performed using laboratory and field samples, achieving a diagnostic specificity of 99%. Importantly, the indirect ELISA was able to detect antibodies to EBOV at 7 dpi, 3 days earlier than virus neutralization tests (VNT). The format of the VNT in this work was modified to a microtitre plaque reduction neutralization assay (miPRNT) complemented with immunostaining to provide a more rapid and highly specific assay. Finally, a confirmatory immunoblot assay was generated to supplement the indirect ELISA results.
© 2017 Her Majesty the Queen in Right of Canada Reproduced with the permission of the Minister of Health and Agriculture, Canadian Food Inspection Agency.

Entities:  

Keywords:  zzm321990ELISAzzm321990; Ebola virus; baculovirus; diagnostics; plaque immunostaining; serology

Mesh:

Substances:

Year:  2017        PMID: 28345293     DOI: 10.1111/tbed.12606

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  3 in total

1.  Serological Detection of Ebola Virus Exposures in Native Non-human Primates of Southern Nigeria.

Authors:  B N Ogunro; B O Olugasa; E J Verschoor; A O Olarinmoye; I Theyse; H Niphuis
Journal:  J Epidemiol Glob Health       Date:  2018-12

2.  Treatment with Ad5-Porcine Interferon-α Attenuates Ebolavirus Disease in Pigs.

Authors:  Chandrika Senthilkumaran; Andrea L Kroeker; Gregory Smith; Carissa Embury-Hyatt; Brad Collignon; Elizabeth Ramirez-Medina; Paul A Azzinaro; Bradley S Pickering; Fayna Diaz-San Segundo; Hana M Weingartl; Teresa de Los Santos
Journal:  Pathogens       Date:  2022-04-08

3.  Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017.

Authors:  Kerstin Fischer; Roland Suluku; Sarah Katharina Fehling; Juliet Jabaty; Bashiru Koroma; Thomas Strecker; Martin H Groschup; Sandra Diederich
Journal:  Emerg Infect Dis       Date:  2020-04       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.